The rs2854116 variant is associated with susceptibility to the development of NAFLD and IR by increasing the plasma concentration of Apoc3 and sequentially inhibiting the clearance of lipoprotein lipase and triglycerides. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.